Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRUVADA for Maternal exposure timing unspecified: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 25 adverse event reports in the FDA FAERS database where TRUVADA was used for Maternal exposure timing unspecified.

Most Reported Side Effects for TRUVADA

Side Effect Reports % Deaths Hosp.
Foetal exposure during pregnancy 41 10.7% 10 8
Renal failure acute 20 5.2% 2 17
Premature baby 19 5.0% 6 4
Thrombocytopenia 16 4.2% 5 11
Exposure during pregnancy 15 3.9% 1 0
Abortion spontaneous 14 3.7% 0 0
Anaemia 14 3.7% 5 10
Diarrhoea 13 3.4% 1 5
Jaundice 11 2.9% 4 7
Pancytopenia 11 2.9% 4 9
Vomiting 11 2.9% 1 6
Fanconi syndrome acquired 10 2.6% 0 2
Lipodystrophy acquired 10 2.6% 0 4
Nausea 10 2.6% 1 4
Pyrexia 10 2.6% 4 7

Other Indications for TRUVADA

Hiv infection (218) Product used for unknown indication (50) Antiretroviral therapy (30) Acquired immunodeficiency syndrome (13) Prophylaxis against hiv infection (13) Hiv test positive (5)

Other Drugs Used for Maternal exposure timing unspecified

VALPROATE (1,477) ADALIMUMAB (1,280) NATALIZUMAB (492) RITONAVIR (486) EMTRICITABINE\TENOFOVIR DISOPROXIL (333) LOPINAVIR\RITONAVIR (278) DIVALPROEX (254) INTERFERON BETA-1A (245) DIMETHYL (212) ATAZANAVIR (169)

Related Pages

TRUVADA Full Profile All Maternal exposure timing unspecified Drugs TRUVADA Demographics TRUVADA Timeline